1. Home
  2. TECH vs NIO Comparison

TECH vs NIO Comparison

Compare TECH & NIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TECH
  • NIO
  • Stock Information
  • Founded
  • TECH 1976
  • NIO 2014
  • Country
  • TECH United States
  • NIO China
  • Employees
  • TECH N/A
  • NIO N/A
  • Industry
  • TECH Biotechnology: Biological Products (No Diagnostic Substances)
  • NIO Auto Manufacturing
  • Sector
  • TECH Health Care
  • NIO Consumer Discretionary
  • Exchange
  • TECH Nasdaq
  • NIO Nasdaq
  • Market Cap
  • TECH 7.9B
  • NIO 7.4B
  • IPO Year
  • TECH 1989
  • NIO 2018
  • Fundamental
  • Price
  • TECH $51.61
  • NIO $4.13
  • Analyst Decision
  • TECH Buy
  • NIO Hold
  • Analyst Count
  • TECH 10
  • NIO 6
  • Target Price
  • TECH $73.44
  • NIO $5.05
  • AVG Volume (30 Days)
  • TECH 2.3M
  • NIO 35.5M
  • Earning Date
  • TECH 05-07-2025
  • NIO 06-05-2025
  • Dividend Yield
  • TECH 0.62%
  • NIO N/A
  • EPS Growth
  • TECH N/A
  • NIO N/A
  • EPS
  • TECH 0.83
  • NIO N/A
  • Revenue
  • TECH $1,208,770,000.00
  • NIO $9,005,433,398.00
  • Revenue This Year
  • TECH $8.19
  • NIO $37.90
  • Revenue Next Year
  • TECH $8.61
  • NIO $26.13
  • P/E Ratio
  • TECH $62.17
  • NIO N/A
  • Revenue Growth
  • TECH 4.72
  • NIO 18.18
  • 52 Week Low
  • TECH $46.44
  • NIO $3.02
  • 52 Week High
  • TECH $85.57
  • NIO $7.71
  • Technical
  • Relative Strength Index (RSI)
  • TECH 49.54
  • NIO 54.77
  • Support Level
  • TECH $46.77
  • NIO $3.82
  • Resistance Level
  • TECH $54.40
  • NIO $4.27
  • Average True Range (ATR)
  • TECH 2.03
  • NIO 0.16
  • MACD
  • TECH 0.70
  • NIO 0.03
  • Stochastic Oscillator
  • TECH 63.43
  • NIO 49.19

About TECH Bio-Techne Corp

Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.

About NIO NIO Inc. American depositary shares each representing one ordinary share

Nio is a leading electric vehicle maker, targeting the premium segment. Founded in November 2014, Nio designs, develops, jointly manufactures, and sells premium smart electric vehicles. The company differentiates itself through continuous technological breakthroughs and innovations such as battery swapping and autonomous driving technologies. Nio launched its first model, its ES8 seven-seater electric SUV, in December 2017, and began deliveries in June 2018. Its current model portfolio includes midsize to large sedans and SUVs. It sold around 222,000 EVs in 2024, accounting for about 2% of the China passenger new energy vehicle market.

Share on Social Networks: